Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals

被引：0
|
作者：
Kappelhoff, BS
Huitema, ADR
Yalvaç, Z
Prins, JM
Beijnen, JH
机构：
[1] Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (08) : 849 - 861
  • [2] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    Bregt S. Kappelhoff
    Alwin D. R. Huitema
    Zeynep Yalvaç
    Jan M. Prins
    Jan W. Mulder
    Pieter L. Meenhorst
    Jos H. Beijnen
    [J]. Clinical Pharmacokinetics, 2005, 44 : 849 - 861
  • [3] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Back, DJ
    Owen, A
    Khoo, SH
    [J]. CLINICAL PHARMACOKINETICS, 2006, 45 (02) : 213 - 214
  • [4] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    David J. Back
    Andrew Owen
    Saye H. Khoo
    [J]. Clinical Pharmacokinetics, 2006, 45 : 213 - 214
  • [5] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals - Reply
    Huitema, ADR
    Beijnen, JH
    [J]. CLINICAL PHARMACOKINETICS, 2006, 45 (02) : 214 - 215
  • [6] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    De Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    Van Gorp, ECM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 552P - 552P
  • [7] Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
    de Maat, MMR
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    van Gorp, ECM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 378 - 385
  • [8] Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
    Aouri, Manel
    Barcelo, Catalina
    Guidi, Monia
    Rotger, Margalida
    Cavassini, Matthias
    Hizrel, Cedric
    Buclin, Thierry
    Decosterd, Laurent A.
    Csajka, Chantal
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [9] Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals
    Arab-Alameddine, M.
    Di Iulio, J.
    Buclin, T.
    Rotger, M.
    Lubomirov, R.
    Cavassini, M.
    Fayet, A.
    Decosterd, L. A.
    Eap, C. B.
    Biollaz, J.
    Telenti, A.
    Csajka, C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) : 485 - 494
  • [10] Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children
    Wintergerst, U.
    Hoffmann, F.
    Jansson, A.
    Notheis, G.
    Huss, K.
    Kurowski, M.
    Burger, D.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) : 1336 - 1339
12345